ATROVENT HFA
BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Quick answers
Is there a shortage of ATROVENT HFA in Canada?
No. There is no current shortage of ATROVENT HFA 20MCG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
JAMP IPRATROPIUM HFA
JAMP PHARMA CORPORATION
Other Products
TEVA-IPRATROPIUM STERINEBS
TEVA CANADA LIMITED
PMS-IPRATROPIUM
PHARMASCIENCE INC
IPRAVENT
AA PHARMA INC
DIN
02247686
Strength
20MCG
Dosage Form
Aerosol (Metered-Dose)
Route
Inhalation
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BOEHRINGER INGELHEIM (CANADA) LTD LTEE
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02242119
250MG · DIN 02273322
DIN 02419106
DIN 02231675
0.4MG · DIN 02270102
30MG · DIN 02415674
20MG · DIN 02415666
40MG · DIN 02415682
DIN 02459752
DIN 02459760
DIN 02441888
10MG · DIN 02443937